1 / 18

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease. Philip Kiely pcdk1e08@soton.ac.uk. Outline. Go through COPD using DAPSICAMP Focus on understanding pathophysiology and clinical features Obstructive vs. Restrictive Lung Disease Respiratory Failure. DAPSICAMP. Definition Aetiology Pathophysiology

svein
Télécharger la présentation

Chronic Obstructive Pulmonary Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chronic Obstructive Pulmonary Disease Philip Kiely pcdk1e08@soton.ac.uk

  2. Outline • Go through COPD using DAPSICAMP • Focus on understanding pathophysiology and clinical features • Obstructive vs. Restrictive Lung Disease • Respiratory Failure

  3. DAPSICAMP Definition Aetiology Pathophysiology Signs and symptoms Investigations Complications Alternative diagnoses Management Prognosis

  4. Definition: COPD is an umbrella term for a spectrum of diseases that result in non-reversible airflow limitation • Typically a combination of chronic bronchitis and emphysema • Chronic bronchitis = a productive cough on most days for 3 months in 2 consecutive years • Emphysema = destruction of airspaces distal to the terminal bronchiole

  5. Facts and stats • COPD represents long-term damage caused by inhaled irritants • Cigarette smoking is the predominant risk factor • Prevalence of 1.5 million; mortality 23,000 per year in the UK • By 2020, it is predicted to become the third leading cause of death worldwide • Currently causes 1 in 8 hospital admissions

  6. Pathophysiology • Damage to the airways results in mucus gland hypertrophy and goblet cell hyperplasia • Inflammation which over time progresses to fibrosis and scarring • Air becomes trapped in the lungs due to mucus plugging of small airways and loss of connective tissue

  7. Signs and symptoms • Tachypnoea (RR > 20) • Use of accessory muscles of respiration • Hyperinflation ( AP diameter, loss of cardiac/liver dullness) • Reduced cricoternal distance • Reduced chest expansion • Cyanosis • Wheeze • Prolonged expiration • Pursed lip breathing

  8. Investigations • Bedside - Spirometry - (FVC < 80% predicted, FEV1:FVC < 70%) • Bloods - normocytic normchromic anaemia (low Hb, normal MCV), raised PCV (> 45%) • Imaging - CXR - hyperinflation, spherical heart, decreased peripheral vascular markings

  9. Complications • Main complications are respiratory failure and cor pulmonale • Respiratory failure (PaO2 < 8 kPa, PaCO2 > 7 kPa) • Cor pulmonale = fluid overload secondary to respiratory disease • Features include raised JVP, ascites and peripheral oedema

  10. Alternative Diagnosis

  11. Management • In treating any condition it is important to understand what you as the clinician are trying to achieve • In COPD, the goals of management are to limit the severity and frequency of acute exacerbations and to limit overall disability = lifestyle advice + pharmacotherapy

  12. Prognosis

  13. Obstructive vs. Restrictive Lung Disease • Obstructive = inability to get air out • Restrictive = inability to get air in • Obstructive lung disease: COPD, Asthma, Bronchiectasis, CF PEFR, FVC, FEV1: FVC • Restrictive Lung Disease: Fibrosis (2º to radiation, medication, asbestos exposure) FEV1, FVC, but normal FEV1: FVC ratio

  14. Respiratory Failure • The term organ failure represents that systems inability to perform its primary function • With the lungs this is oxygenation of the blood and elimination of carbon dioxide • In hypoxaemic respiratory failure (Type I) PaO2 is < 8 kPa, but CO2 is low to normal. This is caused by V/Q mismatching • In hypercapnic respiratory failure (Type II) PaCO2 is > 6.5 kPa, hypoxaemia is also common

More Related